JFG
Jefferies Financial Group Portfolio holdings
AUM
$6.06B
This Quarter Return
+5.16%
1 Year Return
+9.37%
3 Year Return
+16.02%
5 Year Return
+51.04%
10 Year Return
+258.41%
AUM
$6.06B
AUM Growth
+$6.06B
(+4.5%)
Cap. Flow
-$60.7M
Cap. Flow
% of AUM
-1%
Top 10 Holdings %
Top 10 Hldgs %
29.13%
Holding
1,599
New
209
Increased
277
Reduced
318
Closed
555
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$308M |
| 2 |
iShares Russell 2000 ETF
IWM
|
$61.2M |
| 3 |
Intuit
INTU
|
$55.5M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$52.8M |
| 5 |
Capital One
COF
|
$52.6M |
Top Sells
| 1 |
Apple
AAPL
|
$109M |
| 2 |
Meta Platforms (Facebook)
META
|
$74.4M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$67.7M |
| 4 |
Nasdaq
NDAQ
|
$60.7M |
| 5 |
Goldman Sachs
GS
|
$60.1M |
Sector Composition
| 1 | Healthcare | 14.44% |
| 2 | Financials | 12.53% |
| 3 | Technology | 10.24% |
| 4 | Industrials | 7.66% |
| 5 | Energy | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
uniQure
QURE
$896M
| $29.2M | 0.25% | +2,095,931 | New | +$29.2M |
|
52
AbbVie
ABBV
$372B
| $28.4M | 0.24% | 152,796 -26,832 | -15% | -$4.98M |
|
53
Apogee Therapeutics
APGE
$2.17B
| $27.9M | 0.23% | 642,357 +220,561 | +52% | +$9.58M |
|
54
Boston Scientific
BSX
$156B
| $27.7M | 0.23% | 257,639 +168,761 | +190% | +$18.1M |
|
|
55
Apple
AAPL
$3.45T
| $27.3M | 0.23% | 132,871 -532,930 | -80% | -$109M |
|
56
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$42.1B
| $24.6M | 0.21% | 267,668 +124,294 | +87% | +$11.4M |
|
57
NVIDIA
NVDA
$4.24T
| $23.9M | 0.2% | 151,165 +45,176 | +43% | +$7.14M |
|
58
Taysha Gene Therapies
TSHA
$797M
| $23.8M | 0.2% | 10,313,733 +10,068,479 | +4,105% | +$23.3M |
|
59
Walmart
WMT
$774B
| $23.4M | 0.2% | 238,825 +188,446 | +374% | +$18.4M |
|
60
Cidara Therapeutics
CDTX
$1.66B
| $21.9M | 0.18% | +450,000 | New | +$21.9M |
|
61
Regency Centers
REG
$13.2B
| $21.6M | 0.18% | 303,845 -131,845 | -30% | -$9.39M |
|
62
Coterra Energy
CTRA
$18.7B
| $21.2M | 0.18% | 835,149 +157,620 | +23% | +$4M |
|
63
Spyre Therapeutics
SYRE
$996M
| $20.8M | 0.17% | 1,388,854 +140,000 | +11% | +$2.1M |
|
64
Invesco S&P 500 Quality ETF
SPHQ
$15.2B
| $20.2M | 0.17% | 282,958 +10,002 | +4% | +$713K |
|
65
Immunome
IMNM
$828M
| $19.4M | 0.16% | 2,085,660 -202,340 | -9% | -$1.88M |
|
66
SPDR S&P Retail ETF
XRT
$425M
| $19.3M | 0.16% | 250,000 +169,000 | +209% | +$13M |
|
67
Thomson Reuters
TRI
$80B
| $18.9M | 0.16% | +94,106 | New | +$18.9M |
|
68
iShares MSCI USA Quality Factor ETF
QUAL
$54.2B
| $18.3M | 0.15% | 100,102 -401 | -0.4% | -$73.3K |
|
69
Gulfport Energy Corp
GPOR
$3.06B
| $17.3M | 0.15% | 86,079 +23,050 | +37% | +$4.64M |
|
70
Sempra
SRE
$53.9B
| $17.1M | 0.14% | 225,030 +125,380 | +126% | +$9.5M |
|
71
Charles Schwab
SCHW
$174B
| $15.8M | 0.13% | 172,962 +92,592 | +115% | +$8.45M |
|
72
Bank of America
BAC
$376B
| $15.7M | 0.13% | 331,699 +279,980 | +541% | +$13.2M |
|
73
NextEra Energy, Inc.
NEE
$148B
| $15.7M | 0.13% | 225,786 -481,044 | -68% | -$33.4M |
|
74
IBM
IBM
$227B
| $15.5M | 0.13% | 52,645 +17,428 | +49% | +$5.14M |
|
75
Vertex Pharmaceuticals
VRTX
$100B
| $15.4M | 0.13% | 34,615 +15,131 | +78% | +$6.74M |
|